Intermediate-Dose Post-Transplantation Cyclophosphamide (ID-PTCy) after Reduced Intensity Conditioning (RIC) HLA-Mismatched Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Mustafa A Hyder, Shannon R. McCurdy, Ruby Sabina, Dimana Dimitrova, Amy Vicens, Natasha Berryman, Ashley DeVries, Marni Kessler, Amy Chai, Kamil A. Rechache, Christi McKeown, Eleanor McGuire
+17 more Jacqueline Smith, Noelle V. Frey, Saar I. Gill, Elizabeth Olson Hexner, Pashna N. Munshi, Nasheed Mohammad Hossain, Selina M. Luger, Mary Ellen Martin, Catherine Lai, Daria V. Babushok, Ximena Jordan Bruno, Alexander E. Perl, Edward Allen Stadtmauer, David L. Porter, Alison Wakoff Loren, Jennifer Ann Kanakry, Christopher George Kanakry
DOI: 10.1016/j.jtct.2025.12.365
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S256–S257
Publication date
1 February 2026
Language
EN